中东和非洲血脑屏障技术市场预测至 2028 年 - COVID-19 影响和技术区域分析(双特异性抗体 RMT 方法、特洛伊木马方法、增加渗透性、被动扩散和其他非侵入性 BBB 技术)和应用(阿尔茨海默病)疾病、癫痫、帕金森病、多发性硬化症、亨特综合症、脑癌等)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 112    |    Report Code: TIPRE00026227    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Blood Brain Barrier Technologies Market

市场介绍

中东及中东地区非洲地区包括沙特阿拉伯、南非、阿联酋和中东和非洲其他地区。沙特阿拉伯是血脑屏障技术市场的最大市场。由于医疗保健意识的增强和神经退行性疾病的增加,预计沙特阿拉伯的血脑屏障技术市场在预测期内收入将强劲增长。人们对健康问题的认识提高和医疗保健服务消费的增加维持了各种疗法和治疗的巨大市场。沙特阿拉伯政府正在努力改善该国人民的生活。医疗保健服务的改善在过去几年中已从 2006 年占政府总预算的 5.9% 增加到 2014 年的 7.0%。在沙特阿拉伯,医疗保健需求不断增加,政府采取的举措有利于提高民众的参与度私营部门,以扩大私营部门和投资者的规模。

阿联酋和沙特阿拉伯等国家也登记了大量阳性患者。 COVID-19 大流行已成为该地区最重大的挑战。对于该地区脆弱且饱受冲突蹂躏的国家来说,这一挑战尤其令人恐惧——例如伊拉克(1,963,264)、苏丹(38,000)、伊朗(5,378,408)、以色列(1,202,212)和也门(8,527),因为这将导致减少由于全球贸易中断导致进口增加,这进一步加剧了医疗用品和其他商品的短缺,导致价格大幅上涨。由于更多关于血脑屏障技术与COVID-19感染的关系及其对人体影响的研究,本次大流行中的血脑屏障技术市场正在不断增长。因此,大流行对血脑屏障技术市场产生积极影响。

市场概况和动态

中东和中东地区的血脑屏障技术市场非洲市场预计将从 2021 年的 4351 万美元增长到 2028 年的 1.9672 亿美元。预计 2021 年至 2028 年,该市场的复合年增长率为 24.1%。一些神经系统疾病,如中风、神经病、阿尔茨海默病和帕金森病在老年人中更为常见,并且其患病率随着预期寿命的延长而增加。据世界卫生组织称,全球人口正在迅速老龄化。 2015 年至 2050 年间,世界 60 岁以上人口将增加近一倍,从 12% 增至 22%,而老年人中的精神和神经系统疾病可能占到这一时期总伤残调整生命年 (DALY) 的 6.6%年龄阶层。此外,根据同一来源,大约 15% 的 60 岁及以上成年人患有精神障碍。根据疾病预防控制中心 (CDC) 的数据,阿尔茨海默病是 65 岁及以上人群的第五大死因。此外,患有阿尔茨海默病的人数每五年就会翻一番。此外,由于神经系统疾病导致的死亡率也在增加。例如,根据阿尔茨海默氏症协会的数据,三分之一的老年人死于阿尔茨海默氏症或痴呆症。因此,与年龄相关的神经系统疾病患病率的上升增加了血脑屏障技术或更好的药物输送。这一因素正在推动血脑屏障技术市场的增长。

关键细分市场

在技术方面,增加渗透率细分市场在中东和非洲地区占据最大份额。 2021年非洲血脑屏障技术市场。从应用来看,帕金森病细分市场占据中东和非洲地区最大份额。 2021年非洲血脑屏障技术市场。

主要来源和上市公司

准备这份关于中东和中东地区血脑屏障技术市场的报告时提到了一些主要的一手和二手资料来源。非洲有公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司有梯瓦制药工业有限公司(Teva Pharmaceutical Industries Ltd.); F.霍夫曼-拉罗氏有限公司;礼来公司;百时美施贵宝公司;辉瑞公司;和强生公司Johnson Services, Inc. 等

购买报告的理由< /u>

  • 了解中东和中东地区非洲血脑屏障技术市场格局并确定最有可能保证强劲回报的细分市场
  • 了解中东不断变化的竞争格局,保持领先地位&非洲血脑屏障技术市场
  • 高效规划中东和非洲地区的并购和合作交易通过确定最有希望销售的细分市场,非洲血脑屏障技术市场
  • 通过对中东各个细分市场的市场表现进行敏锐和全面的分析,帮助做出明智的业务决策&非洲血脑屏障技术市场
  • 获取2021-2028年中东和非洲各细分市场的市场收入预测非洲地区

中东和非洲地区非洲血脑屏障技术市场细分

中东和非洲非洲血脑屏障技术市场 –按技术

  • 双特异性抗体RMT方法
  • 特洛伊木马方法
  • 增加渗透性
  • 被动扩散
  • 其他非侵入性 BBB 技术

中东和中东地区非洲血脑屏障技术市场 –通过

应用

  • 阿尔茨海默病< /li>
  • 癫痫
  • 帕金森病
  • 多发性硬化症
  • 猎人综合症
  • 脑癌
  • 其他
  • >

中东和中东地区非洲血脑屏障技术市场 –按国家/地区

  • 沙特阿拉伯
  • 南非< /li>
  • 阿联酋
  • 中东和非洲其他地区

中东及中东地区非洲血脑屏障技术市场 –提及的公司

  • 梯瓦制药工业有限公司                             ;       
  • F.霍夫曼罗氏有限公司                                   ;           
  • 礼来公司和公司      ;                  &n公共服务提供商;                  &n公共服务提供商;          
  • 百时美施贵宝公司    ;                  &n公共服务提供商;                 
  • 辉瑞公司                                  ;                     ;                   
  • 强生公司约翰逊服务公司                  ;                   < /span>


Middle East & Africa Blood Brain Barrier Technologies Strategic Insights

Strategic insights for Middle East & Africa Blood Brain Barrier Technologies involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/middle-east-and-africa-blood-brain-barrier-technologies-market-strategic-framework.webp
Get more information on this report

Middle East & Africa Blood Brain Barrier Technologies Report Scope

Report Attribute Details
Market size in 2021 US$US$ 43.51 Million
Market Size by 2028 US$ 196.72 Million
Global CAGR (2021 - 2028) 24.1%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By 技术
  • 双特异性抗体 RMT 方法
  • 特洛伊木马方法
  • 增加渗透性
  • 被动扩散
  • 其他非侵入性 BBB 技术
By 应用
  • 阿尔茨海默病
  • 癫痫
  • 帕金森病
  • 多发性硬化症
  • 亨特氏综合症
  • 脑癌
Regions and Countries Covered 中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
Market leaders and key company profiles
  • Teva Pharmaceutical Industries Ltd.
  • F. Hoffmann-La Roche Ltd
  • Eli Lilly and Company
  • Bristol-Myers Squibb Company
  • Pfizer, Inc.
  • Johnson & Johnson Services, Inc.
  • Get more information on this report

    Middle East & Africa Blood Brain Barrier Technologies Regional Insights

    The regional scope of Middle East & Africa Blood Brain Barrier Technologies refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/middle-east-and-africa-blood-brain-barrier-technologies-market-geography.webp
    Get more information on this report

    The List of Companies - Middle East & Africa Blood Brain Barrier Technologies Market

    1. Teva Pharmaceutical Industries Ltd.                                         
    2. F. Hoffmann-La Roche Ltd                                                            
    3. Eli Lilly and Company                                                                    
    4. Bristol-Myers Squibb Company                                                   
    5. Pfizer, Inc.                                                                                        
    6. Johnson & Johnson Services, Inc.                                               
    Frequently Asked Questions
    How big is the Middle East & Africa Blood Brain Barrier Technologies Market?

    The Middle East & Africa Blood Brain Barrier Technologies Market is valued at US$US$ 43.51 Million in 2021, it is projected to reach US$ 196.72 Million by 2028.

    What is the CAGR for Middle East & Africa Blood Brain Barrier Technologies Market by (2021 - 2028)?

    As per our report Middle East & Africa Blood Brain Barrier Technologies Market, the market size is valued at US$US$ 43.51 Million in 2021, projecting it to reach US$ 196.72 Million by 2028. This translates to a CAGR of approximately 24.1% during the forecast period.

    What segments are covered in this report?

    The Middle East & Africa Blood Brain Barrier Technologies Market report typically cover these key segments-

  • 技术 (双特异性抗体 RMT 方法, 特洛伊木马方法, 增加渗透性, 被动扩散, 其他非侵入性 BBB 技术)
  • 应用 (阿尔茨海默病, 癫痫, 帕金森病, 多发性硬化症, 亨特氏综合症, 脑癌)
  • What is the historic period, base year, and forecast period taken for Middle East & Africa Blood Brain Barrier Technologies Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Blood Brain Barrier Technologies Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Middle East & Africa Blood Brain Barrier Technologies Market?

    The Middle East & Africa Blood Brain Barrier Technologies Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Teva Pharmaceutical Industries Ltd.
  • F. Hoffmann-La Roche Ltd
  • Eli Lilly and Company
  • Bristol-Myers Squibb Company
  • Pfizer, Inc.
  • Johnson & Johnson Services, Inc.
  • Who should buy this report?

    The Middle East & Africa Blood Brain Barrier Technologies Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East & Africa Blood Brain Barrier Technologies Market value chain can benefit from the information contained in a comprehensive market report.